Hologic: Company Profile

Published: December 14, 2015 | Price: $175.00 – $350.00

Hologic: Company Profile Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm...

The World Market for Cancer Therapeutics: Forecasts to 2020 (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

Published: November 12, 2015 | Price: $2,100.00 – $4,200.00

This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types) including Monoclonal Antibodies, Tyrosine Kinase, Inhibitors, Cancer Vaccines, Cytokines, Gene Therapy, Traditional Chemotherapy. The report has a special emphasis on novel treatments and provides an overview of...

Roche Diagnostics: Company Profile

Published: November 2, 2015 | Price: $250.00 – $500.00

Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...

Mergers and Acquisitions in the IVD Market, October 2015

Published: October 26, 2015 | Price: $499.00 – $1,000.00

Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....

The World Market for Molecular Diagnostics, 2014-2019, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others)

Published: September 30, 2015 | Price: $1,999.00 – $3,995.00

Molecular tests are used in just about every facet of laboratory medicine: infectious diseases, inherited diseases, coagulation, transplant medicine, prenatal and postnatal screening and cancer.  In The World Market for Molecular Diagnostics, 6th Edition, Kalorama IVD market analyst Shara Rosen, R.T., MBA provides authoritative and complete analysis of the molecular testing industry. In this report, exclusive market sizing and forecasts are provided for the following diagnostic segments: Cancer Markers & PGx Histology (In situ hybridization, HPV) Microbiology/Virology (HAI; HIV; Hepatitis;...

The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays)

Published: September 11, 2015 | Price: $1,995.00 – $3,995.00

The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, 6th Edition., as well as relevant industry merger data provided by Kalorama Information,...

The IVD Market in Vietnam: Forecasts to 2019

Published: August 19, 2015 | Price: $1,995.00 – $3,990.00

The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry.  Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia.  As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam.  The report takes an in-depth look at the market, providing data...

Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)

Published: August 17, 2015 | Price: $499.00 – $1,000.00

What’s happening in biotechnology in the fastest-growing economies of the world?  Who are the leaders operating in these nations and what partnerships have they completed?  This report provides answers and informs readers of the companies they need to know about.  Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today’s biotech market in the countries outside the United States and Europe. The report identifies eight important emerging company markets and...